The top health research institute said that an adjuvant developed with funding from the NIH has contributed to the success of the "highly efficacious" COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere.
All COVID-19 vaccinations scheduled for Wednesday at government-run centres in Gautam Buddh Nagar have been deferred to July 6, officials said on Tuesday.
India has topped the global vaccination chart against Covid-19. The counry has administered 32.36 crore doses.
Over 2.05 lakh people in Delhi received anti-coronavirus vaccine shots on Saturday, the highest in a day till now, said Deputy Chief Minister Manish Sisodia.
More than 1.45 crore COVID-19 vaccine doses are still available with states and union territories and over 19,10,650 jabs are in the pipeline.
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
As per WHO guidelines, Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. It has already submitted 90 per cent of documents to WHO for obtaining EUL for Covaxin
The Gurugram health department has announced a price cap for the administration of Covid-19 vaccines in private hospitals.
India on Tuesday administered around 53 lakh doses of Covid-19 vaccines. This is a nearly 40 per cent drop from Monday’s record-breaking 88 lakh inoculations.
Hyderabad-based Bharat Biotech has been facing tough questions over the delay in announcing its phase 3 trial data of the vaccine.
The Union Health Ministry has said that over 85.15 lakh vaccine doses, the highest in a single day, were administered across the country on Monday.
The United States has announced a plan to share 55 million of the 80 million Covid-19 vaccine doses promised to the world by President Joe Biden.
Bharat Biotech's Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its vaccine have been questioned various times and that is what makes the data crucial which will ascertain the efficacy of the vaccine.
With Delhi receiving fresh stock of 1,67,000 Covishield doses for people in the 18-44 age group, the total number of Covid vaccines available for the group has now gone up to 2,95,000, senior AAP leader and MLA Atishi said on Saturday.
Bharat Biotech had said last month that it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Listing (EUL) during July-September.
The Union Health Ministry has said that some social media posts have distorted facts that the indigenously manufactured Covaxine contains the serum of a newborn calf. The Health Ministry said that the serum of the newborn calf is used only for the preparation and development of Vero cells
BJP today slammed India National Congress on June 16 after members of INC including Pawan Khera and Gaurav Pandhi alleged that Covaxin contains serum of calf in it.
Bharatiya Janata Party national spokesperson Sambit Patra slammed India National Congress on June 16 after members of INC including Pawan Khera and Gaurav Pandhi alleged that Covaxin contains serum of calf in it.
The Centre on Wednesday clarified that the Covaxin does not contain the newborn calf serum, saying the facts have been "twisted and misrepresented" in some social media posts. "Newborn calf serum is used only for the preparation and growth of vero cells. Serum from bovine and other animal are standard enrichment ingredient used globally for vero cell growth," the Union Health Ministry said in a statement.
Newborn calf serum is used only for the preparation and growth of vero cells. Serum from bovine and other animal are standard enrichment ingredient used globally for vero cell growth, the Union Health Ministry said in a statement
Top News
Latest News
